Variations of BCOR, MYCN, NOTCH1, and PIK3R1 and positive immunohistochemistry for S100 showed statistically significant results in univariate survival analysis in WHO grade 4 astrocytoma (Figure S2). This evidence concerns the gene BCOR and astrocytoma (excluding glioblastoma).